Antitumour immune responses.

Roshni Mitra, Sarvjeet Singh, Ashok Khar

Research output: Contribution to journalReview article

Abstract

The role of the immune system in combating tumour progression has been studied extensively. The two branches of the immune response - humoral and cell-mediated - act both independently and in concert to combat tumour progression, the success of which depends on the immunogenicity of the tumour cells. The immune system discriminates between transformed cells and normal cells by virtue of the presence of unique antigens on tumour cells.Despite this, the immune system is not always able to detect and kill cancerous cells because neoplasms have also evolved various strategies to escape immune surveillance. Attempts are being made to trigger the immune system into an early and efficient response against malignant cells, and various therapeutic modalities are being developed to enhance the strength of the immune response against tumours. This review aims to elucidate the tumoricidal role of various components of the immune system, including macrophages, lymphocytes, dendritic cells and complement.

Original languageEnglish (US)
Pages (from-to)1-19
Number of pages19
JournalExpert Reviews in Molecular Medicine
Volume5
Issue number3
StatePublished - Jan 1 2003

Fingerprint

Immune system
Tumors
Immune System
Neoplasms
Cells
Lymphocytes
Macrophages
Neoplasm Antigens
Humoral Immunity
Dendritic Cells
Antigens

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)
  • Molecular Medicine

Cite this

Mitra, R., Singh, S., & Khar, A. (2003). Antitumour immune responses. Expert Reviews in Molecular Medicine, 5(3), 1-19.

Antitumour immune responses. / Mitra, Roshni; Singh, Sarvjeet; Khar, Ashok.

In: Expert Reviews in Molecular Medicine, Vol. 5, No. 3, 01.01.2003, p. 1-19.

Research output: Contribution to journalReview article

Mitra, R, Singh, S & Khar, A 2003, 'Antitumour immune responses.', Expert Reviews in Molecular Medicine, vol. 5, no. 3, pp. 1-19.
Mitra R, Singh S, Khar A. Antitumour immune responses. Expert Reviews in Molecular Medicine. 2003 Jan 1;5(3):1-19.
Mitra, Roshni ; Singh, Sarvjeet ; Khar, Ashok. / Antitumour immune responses. In: Expert Reviews in Molecular Medicine. 2003 ; Vol. 5, No. 3. pp. 1-19.
@article{2b0ac12e4d994ca2aa4be9e924f514a5,
title = "Antitumour immune responses.",
abstract = "The role of the immune system in combating tumour progression has been studied extensively. The two branches of the immune response - humoral and cell-mediated - act both independently and in concert to combat tumour progression, the success of which depends on the immunogenicity of the tumour cells. The immune system discriminates between transformed cells and normal cells by virtue of the presence of unique antigens on tumour cells.Despite this, the immune system is not always able to detect and kill cancerous cells because neoplasms have also evolved various strategies to escape immune surveillance. Attempts are being made to trigger the immune system into an early and efficient response against malignant cells, and various therapeutic modalities are being developed to enhance the strength of the immune response against tumours. This review aims to elucidate the tumoricidal role of various components of the immune system, including macrophages, lymphocytes, dendritic cells and complement.",
author = "Roshni Mitra and Sarvjeet Singh and Ashok Khar",
year = "2003",
month = "1",
day = "1",
language = "English (US)",
volume = "5",
pages = "1--19",
journal = "Expert Reviews in Molecular Medicine",
issn = "1462-3994",
publisher = "Cambridge University Press",
number = "3",

}

TY - JOUR

T1 - Antitumour immune responses.

AU - Mitra, Roshni

AU - Singh, Sarvjeet

AU - Khar, Ashok

PY - 2003/1/1

Y1 - 2003/1/1

N2 - The role of the immune system in combating tumour progression has been studied extensively. The two branches of the immune response - humoral and cell-mediated - act both independently and in concert to combat tumour progression, the success of which depends on the immunogenicity of the tumour cells. The immune system discriminates between transformed cells and normal cells by virtue of the presence of unique antigens on tumour cells.Despite this, the immune system is not always able to detect and kill cancerous cells because neoplasms have also evolved various strategies to escape immune surveillance. Attempts are being made to trigger the immune system into an early and efficient response against malignant cells, and various therapeutic modalities are being developed to enhance the strength of the immune response against tumours. This review aims to elucidate the tumoricidal role of various components of the immune system, including macrophages, lymphocytes, dendritic cells and complement.

AB - The role of the immune system in combating tumour progression has been studied extensively. The two branches of the immune response - humoral and cell-mediated - act both independently and in concert to combat tumour progression, the success of which depends on the immunogenicity of the tumour cells. The immune system discriminates between transformed cells and normal cells by virtue of the presence of unique antigens on tumour cells.Despite this, the immune system is not always able to detect and kill cancerous cells because neoplasms have also evolved various strategies to escape immune surveillance. Attempts are being made to trigger the immune system into an early and efficient response against malignant cells, and various therapeutic modalities are being developed to enhance the strength of the immune response against tumours. This review aims to elucidate the tumoricidal role of various components of the immune system, including macrophages, lymphocytes, dendritic cells and complement.

UR - http://www.scopus.com/inward/record.url?scp=4344641622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344641622&partnerID=8YFLogxK

M3 - Review article

C2 - 14987405

VL - 5

SP - 1

EP - 19

JO - Expert Reviews in Molecular Medicine

JF - Expert Reviews in Molecular Medicine

SN - 1462-3994

IS - 3

ER -